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nasopharyngeal microbiota of children in Fiji
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Abstract
Background: Streptococcus pneumoniae is a significant global pathogen that colonises the nasopharynx of healthy
children. Pneumococcal conjugate vaccines, which reduce nasopharyngeal colonisation of vaccine-type S. pneumoniae,
may have broader effects on the nasopharyngeal microbiota; however, data are limited. In Fiji, nasopharyngeal carriage
prevalence of S. pneumoniae and other colonising species differ between the two main ethnic groups. Here, we
examined the association between the 7-valent pneumococcal conjugate vaccine (PCV7) and the nasopharyngeal
microbiota of children in Fiji, including for each of the two main ethnic groups—indigenous Fijians (iTaukei) and Fijians
of Indian descent (FID).
Method: The nasopharyngeal microbiota of 132 Fijian children was examined using nasopharyngeal swabs collected
from 12-month-old iTaukei and FID children who were vaccinated (3 doses PCV7) or unvaccinated in infancy as part of
a phase II randomised controlled trial. Microbiota composition was determined by sequencing the V4 region of the
16S rRNA gene. Species-specific carriage of S. pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and
Staphylococcus aureus was determined using real-time quantitative PCR. Associations between microbiota
composition and other host and environmental factors were considered in the analysis.
Results: PCV7 had no overall impact on microbial diversity or composition. However, ethnic differences were
observed in both diversity and composition with iTaukei children having higher relative abundance of Moraxella
(p = 0.004) and Haemophilus (p = 0.004) and lower relative abundance of Staphylococcus (p = 0.026),
Dolosigranulum (p = 0.004) and Corynebacterium (p = 0.003) compared with FID children. Further, when we
stratified by ethnicity, associations with PCV7 could be detected: vaccinated iTaukei children had a lower
relative abundance of Streptococcus and Haemophilus compared with unvaccinated iTaukei children (p = 0.022
and p = 0.043, respectively); and vaccinated FID children had a higher relative abundance of Dolosigranulum
compared with unvaccinated FID children (p = 0.037). Children with symptoms of an upper respiratory tract
infection (URTI) had a significantly different microbiota composition to children without symptoms. The microbiota
composition of iTaukei children without URTI symptoms was most similar to the microbiota composition of FID
children with URTI symptoms.
Conclusions: Associations between PCV7 and nasopharyngeal microbiota differed within each ethnic group. This
study highlights the influence that ethnicity and URTIs have on nasopharyngeal microbiota.
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Background
Streptococcus pneumoniae (the pneumococcus) is a
Gram-positive bacterium that causes a range of diseases,
including otitis media, pneumonia and meningitis, and is
a major cause of morbidity and mortality in children
under 5 years of age worldwide [1]. Colonisation of the
nasopharynx by S. pneumoniae is generally asymptom-
atic and is considered a precursor for pneumococcal dis-
ease [2, 3]. Pneumococcal conjugate vaccines (PCVs)
target the pneumococcal capsular polysaccharide of
common disease-causing serotypes, with current paedi-
atric vaccine formulations targeting 10 or 13 out of over
90 known serotypes [4]. PCVs provide direct protection
against infection and carriage. The reduction in vaccine-
type carriage in vaccinees reduces transmission to un-
vaccinated individuals, thereby resulting in indirect
(herd) effects [5–7]. In settings where PCVs have been
introduced, serotype replacement has occurred, whereby
serotypes not included in PCVs have become more
prominent in carriage and disease [8, 9]. There is con-
flicting evidence about whether species replacement can
also occur following pneumococcal vaccination, with
mixed evidence for the common respiratory pathogens
Haemophilus influenzae, Moraxella catarrhalis and
Staphylococcus aureus [10–13]. Interactions with S.
pneumoniae are thought to underpin vaccine-related
changes in prevalence for these pathogens, with a nega-
tive interaction between S. pneumoniae and S. aureus,
and generally positive associations between S. pneumo-
niae and H. influenzae, and S. pneumoniae and M. cat-
arrhalis [14–17].
There is some evidence that PCVs may alter nasopha-
ryngeal bacterial composition and diversity; however,
findings have not been consistent across the four pub-
lished studies [18–21]. Biesbroek et al. found that the 7-
valent pneumococcal conjugate vaccine (PCV7) was as-
sociated with shifts in microbial composition and in-
creases in bacterial diversity in Dutch children at 12, but
not at 24, months of age [18]. In contrast, Feazel et al.
found the 10-valent pneumococcal conjugate vaccine
(PCV10) had no effect on the microbiome of Kenyan
children (aged 12–59 months) 180 days after vaccination
[19]. Two studies have been done in Swiss children. In
children < 2 years of age with acute otitis media, PCV7
reduced the prevalence of commensal families [20]. The
other study in healthy infants over the first year of life
found that children vaccinated in the 13-valent pneumo-
coccal conjugate vaccine (PCV13) era had higher micro-
bial diversity and microbiota stability than children
vaccinated in the PCV7 era; this was likely associated
with the lower pneumococcal carriage prevalence in the
PCV13 era [21].
Carriage prevalence of bacterial species can vary by geo-
graphic region and socio-economic status [22, 23]. Children
in low- and middle-income countries, and susceptible pop-
ulations in high-income settings, often have a high preva-
lence of pneumococcal colonisation, suggesting that the
impact of vaccination on the microbiome could be different
in these settings compared with children in developed
countries [22].
There are two main ethnic groups in Fiji, indigenous
Fijians (iTaukei) and Fijians of Indian descent (FID). The
iTaukei have higher carriage prevalence of S. pneumo-
niae and higher burden of pneumococcal disease com-
pared with FID [24, 25]. Previously, we conducted the
Fiji Pneumococcal Project (FiPP), a randomised phase II
vaccine trial that evaluated various schedules of PCV7
followed by the 23-valent pneumococcal polysaccharide
vaccine as a booster at 12 months of age [26–29]. Re-
sults from FiPP at 17 months of age, and a long-term
follow-up to the study, highlighted differences in car-
riage prevalence of S. pneumoniae, S. aureus, H. influ-
enzae and M. catarrhalis between the two main
ethnic groups [25, 30], suggesting they have distinct
microbial profiles. We also found that the 23-valent
pneumococcal polysaccharide vaccine given at 12
months of age had differential effects on long-term
carriage of S. pneumoniae and S. aureus for the two
ethnic groups [30].
Therefore, we hypothesise that PCVs may have differ-
ential effects on microbiota depending on the ethnicity
of the child. To examine this directly, we used samples
collected as part of the FiPP to determine the association
between PCV and nasopharyngeal microbiota in Fijian
children aged 12 months, including specific associations
within each ethnic group.
Results
Overall, 144 samples (36 samples each from unvaccin-
ated iTaukei children, PCV7 vaccinated iTaukei chil-
dren, unvaccinated FID children and PCV7 vaccinated
FID children), 4 sample repeats, 7 extraction controls
and 5 PCR (no template) controls were sequenced
resulting in a total of 62,038,435 sequence reads and
an average of 387,740 reads per sample. Following se-
quence processing, 59% (36,344,642 total; 227,154 per
sample) of these sequence reads remained for ana-
lysis. Twelve samples were excluded because they
shared greater than 20% sequence read similarity with
controls (n = 11) or had fewer than 50,000 sequence
reads (n = 1). In the remaining 132 samples, we iden-
tified 4036 operational taxonomic units (OTUs) in
total and 847 OTUs with unique taxonomic names.
The most common genera (Dolosigranulum, Pseudo-
monas, Corynebacterium, Moraxella, Haemophilus,
Streptococcus and Staphylococcus) accounted for at
least 90% of all sequence reads in 118 out of the 132
(89%) of samples.
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Study participant characteristics
Participant characteristics by ethnicity and vaccination
status are shown in Table 1. There were few differences
between unvaccinated and vaccinated children within
each ethnic group, although among FID children, there
were fewer males in the unvaccinated group compared
with the vaccinated group and vaccinated children were
slightly heavier. There was some evidence that fewer vac-
cinated FID children used antibiotics in the previous 2
weeks compared with unvaccinated FID children (0% vs.
13%). There was also some evidence that a greater num-
ber of unvaccinated iTaukei children were breastfed at
the time of swab collection compared with vaccinated
iTaukei children (79% vs. 56%). Pooled participant char-
acteristics by both vaccination status and by ethnicity
were also considered (see Additional file 1: Tables S1
and S2), with a higher proportion of unvaccinated chil-
dren breastfed compared with vaccinated children (74%
vs. 54%, p = 0.019). Mean weight was higher in iTaukei
children compared with FID children (5023 g vs. 4382 g,
p < 0.001) and more iTaukei children were exposed to
cigarette smoke than FID children (55% vs. 18%, p =
0.038).
Overall association between PCV7 and nasopharyngeal
microbiota
PCV7 vaccination had no significant association with
the richness of nasopharyngeal microbiota (median
number of OTUs in unvaccinated children 84 vs. 62 in
vaccinated children, p = 0.137) or Shannon diversity
(median of 1.36 in unvaccinated children vs. 1.28 in vac-
cinated children, p = 0.115) (see Additional file 2: Figure
S1a and S1b). We explored differences in overall
microbial composition between unvaccinated and vacci-
nated children, using Jaccard dissimilarity (both
abundance-based and binary-based) and using non-
metric multidimensional scaling (nMDS) plots as an or-
dination method. Overall, vaccination appeared to have
little impact on the microbial composition of the naso-
pharynx regardless of whether abundance-based (Fig. 1a,
p = 0.668) or binary-based (Fig. 1b, p = 0.893) dissimilar-
ity was considered. Looking specifically at the seven
most common genera (Table 2), PCV7 was only associ-
ated with changes to the relative abundance of Strepto-
coccus (p = 0.030), with a lower relative abundance of
Streptococcus in vaccinated children (median 0.59%)
compared with unvaccinated children (median 1.02%).
The random forest model considering the association
between PCV7 vaccination and microbial composition
was not significant (p = 0.836). As the 16S sequencing
analysis was generally limited to genus level, we exam-
ined carriage prevalence and density of the common re-
spiratory pathogens S. pneumoniae, H. influenzae, M.
catarrhalis and S. aureus using species-specific real-time
quantitative PCR (qPCR), finding no differences between
unvaccinated children and vaccinated children (Add-
itional file 3:Figure S2).
Ethnic differences
We next examined difference in nasopharyngeal micro-
biota by ethnic group. While the ethnicity of a child did
not influence OTU richness (median number of OTUs
in iTaukei children of 68 vs. 72 in FID children, p =
0.436), it did have an influence on Shannon diversity.
OTUs were more evenly spread in iTaukei children com-
pared with FID children (median Shannon diversity
Table 1 Participant characteristics for children aged 12months by PCV vaccination status within each ethnic group
Characteristics at swab collection No PCV7 iTaukei
(n = 33)
PCV7 iTaukei
(n = 34)
p value No PCV7 FID
(n = 32)
PCV7 FID
(n = 33)
p value
Male, n (%) 18 (55) 19 (56) 1.000 12 (38) 22 (67) 0.026
Swab collected in wet season1, n (%) 25 (76) 28 (82) 0.560 25 (78) 20 (61) 0.180
Mean weight2 in g (SD) 4998 (584) 5084 (579) 0.658 4243 (547) 4566 (443) 0.018
Breastfeeding, n (%) 26 (79) 19 (56) 0.068 22 (69) 17 (52) 0.208
Median age breastfeeding stopped3 in wks (IQR) 26 (26-40) 28 (18-35) 0.523 9 (2-31) 27 (15-40) 0.086
Exposure to cigarette smoking, n (%) 21 (64) 16 (47) 0.222 12 (38) 12 (36) 1.000
Prior antimicrobial use4, n (%) 4 (12) 5 (15) 1.000 4 (13) 0 (0) 0.053
Symptoms of URTI [any], n (%) 11 (33) 14 (41) 0.615 8 (25) 6 (18) 0.558
Runny nose, n (%) 10 (30) 9 (26) 0.791 6 (19) 5 (15) 0.751
Cough, n (%) 7 (21) 10 (29) 0.576 4 (13) 5 (15) 1.000
URTI upper respiratory tract infection, SD standard deviation, iTaukei indigenous Fijian, FID Fijian of Indian Descent, Statistically significant differences (p < 0.05) as
calculated by Fisher’s Exact test are shown in italics.
1Wet season = November–April
2Weight data were incomplete for vaccinated children—13/34 available for iTaukei children, 24/33 available for FID children
3Data only included for children that had stopped breastfeeding
4Antimicrobial use in the prior two weeks as reported by parent/guardian
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index of 1.33 vs. 1.07, p = 0.006) (see Additional file 2:
Figure S1c and S1d). The overall microbial composition
of the nasopharynx was significantly different between
iTaukei and FID children using both abundance-based (p
< 0.001) and binary-based measures (p < 0.001) (Fig.1c
and d). Of the most common genera (Table 2), iTaukei
children had higher relative abundance of Moraxella and
Haemophilus and lower relative abundance of Staphylo-
coccus, Dolosigranulum and Corynebacterium. The ran-
dom forest model also showed an association between
Fig. 1 nMDS of the dissimilarity in microbial composition using both abundance-based and binary-based measures by vaccination status (a and
b, respectively), by ethnicity (c and d, respectively), in iTaukei children by vaccination status (e and f, respectively) and in FID children by vaccination
status (g and h, respectively). The centre points represent the mean of each group and the lines represent distance from the mean for each sample.
p values calculated using PERMANOVA. Stress values for figures are 0.158 (a and c), 0.216 (b and d), 0.154 (e), 0.218 (f), 0.149 (g) and 0.215 (h)
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ethnicity and microbial composition (p < 0.001). The most
important OTUs in the random forest model included
Corynebacterium, Staphylococcus and Moraxella, as well
as less abundant OTUs Helcococcus, Acinetobacter and
Prevotella (Fig. 2a). This Helcococcus OTU was more
prevalent in iTaukei children compared with FID children
(78% in iTaukei vs. 52% in FID children, p = 0.003) and
was also present at a higher relative abundance (median
relative abundance of 0.4% in iTaukei children vs. 0.001%
in FID children, p < 0.001). By species-specific qPCR, the
carriage prevalence of S. pneumoniae, H. influenzae and
M. catarrhalis was higher in iTaukei children than FID
children (69% vs. 26%, 69% vs. 28% and 91% vs. 37%, re-
spectively, all p < 0.001). The carriage prevalence of S.
aureus was similarly low in iTaukei children (4%) and FID
children (6%). No differences in species-specific density
between ethnic groups were observed (Additional file 3:
Figure S3).
Association between PCV7 and nasopharyngeal
microbiota within each ethnic group
Given the differences in microbiota composition between
ethnic groups, we examined the association between
PCV7 and nasopharyngeal microbiota after stratifying by
ethnicity. There were no significant differences in OTU
richness or Shannon diversity between unvaccinated and
vaccinated children within either ethnic group (iTaukei
children: median of 84 OTUs and 1.36 Shannon diversity
in unvaccinated children vs. 62 OTUs and 1.28 Shannon
diversity in vaccinated children, p = 0.098 and 0.115, re-
spectively; FID children: median of 70 OTUs and 1.11
Shannon diversity in unvaccinated children vs. 71 OTUs
and 1.00 Shannon diversity in vaccinated children, p =
0.095 and 0.662, respectively) (see Additional file 2: Figure
S1e and S1f). nMDS analyses suggested PCV7 had little
association with the nasopharyngeal microbiota of
iTaukei children using both abundance-based (p =
0.375) and binary-based (p = 0.155) measures (Fig. 1e
and f ). There was some evidence that PCV7 was as-
sociated with nasopharyngeal microbial composition
of FID children using an abundance-based measure (p
= 0.05) but not a binary-based measure (p = 0.479)
(Fig. 1g and h), suggesting that PCV7 may impact the
relative abundance, but not the presence, of OTUs in
FID children. Random forest models showed no asso-
ciation between microbial composition and vaccin-
ation within either ethnic group (p = 0.952 in Taukei
children and p = 0.512 in FID children).
In iTaukei children, unvaccinated children had higher
relative abundance of Streptococcus compared with vacci-
nated children (Table 2). Similarly, unvaccinated iTaukei
children had a higher relative abundance of Haemophilus
compared with vaccinated iTaukei children. No other dif-
ferences in the most common genera between unvaccin-
ated and vaccinated iTaukei children were seen.
In FID children, those that were unvaccinated had
lower relative abundance of Dolosigranulum compared
with children who received PCV7 (Table 2). No other
PCV7-associated differences in common genera were
observed in FID children.
Using species-specific qPCR assays, we examined car-
riage prevalence and density within each ethnic group
for S. pneumoniae, H. influenzae, M. catarrhalis and S.
aureus comparing unvaccinated and vaccinated children
(Additional file 3: Figure S4). Within each ethnic group,
there were no significant differences in carriage preva-
lence or density by vaccination status for any of the four
bacterial species examined.
a
b
Fig. 2 Top ten most important OTUs (as ranked by mean decrease
in accuracy) in random forest models for ethnicity (a) and symptoms
of an URTI (b). Only ten OTUs are shown to highlight the most
significant OTUs that separate iTaukei and FID children, and children
with and without symptoms of an URTI
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Symptoms of an upper respiratory tract infection
We examined the association between other factors (sea-
sonality, exposure to cigarette smoke, antibiotic use in
the previous 2 weeks, year of swab collection, sex,
current breastfeeding status and symptoms of an upper
respiratory tract infection (URTI)—either cough or
runny nose) and overall microbiota composition (Add-
itional file 1: Table S1). Only the presence of symptoms
of an URTI had a significant impact on microbial com-
position. In the random forest model for URTI symp-
toms (p = 0.012), the most important OTUs were
Staphylococcus, an unclassified Pasteurellaceae OTU,
Haemophilus, Moraxella, Veillonella and Helcococcus
(Fig. 2b). Compared with children without URTI symp-
toms, children with URTI symptoms had higher relative
abundance of Moraxella, Haemophilus and Streptococcus
and lower relative abundance of Dolosigranulum and
Corynebacterium (Table 3).
Interestingly, not only did children with symptoms
of an URTI have significantly different microbiota
compared with children without symptoms, but the
microbiota composition of iTaukei children without
URTI symptoms was most similar to the microbiota
composition of FID children with URTI symptoms
(Fig. 3). When analysis of the most common genera
was stratified by ethnicity, the relative abundance in
Haemophilus was higher in iTaukei children with
URTI symptoms compared to those without symp-
toms (Additional file 1: Table S2). No other signifi-
cant differences were observed, but trends were
consistent in both ethnic groups and with the overall
results shown in Table 3.
Microbial composition and dominant taxa
We next looked at microbial composition in the samples
by generating a heatmap and clustering samples based on
their composition using a Jaccard distance matrix (Fig. 4).
Most samples were dominated by one or two taxa with
the following clusters identified by their dominant taxa
(Fig. 3): Cluster 2 (n = 36) dominated by Moraxella;
Cluster 3 (n = 22) dominated by Dolosigranulum; Cluster
4 (n = 34) dominated by Dolosigranulum; Cluster 5 (n =
16) dominated by Haemophilus and Corynebacterium;
and Cluster 6 (n = 20) dominated by Pseudomonas. Clus-
ter 1 contained four samples that did not fit into any of
the other clusters.
Associations between clusters and host factors were
considered, with several clusters associated with ethnicity
and symptoms of an URTI. Compared with iTaukei chil-
dren, FID children were more likely to have a cluster 4
microbiota profile (40% FID children vs. 12% iTaukei chil-
dren, p < 0.001) and less likely to have a cluster 2 micro-
biota profile (17% FID children vs. 37% iTaukei children, p
= 0.011). Cluster 4 was associated with a higher propor-
tion of children without URTI symptoms (31% no URTI
children vs. 13% URTI children, p = 0.030). There was also
some evidence that cluster 5 and cluster 2 were associated
with symptoms of an URTI (9% no URTI children vs. 21%
URTI children, p = 0.078; and 23% no URTI children vs.
38% URTI children, p = 0.086, respectively).
Owing to concern that Pseudomonas was a potential
contaminant, we cultured eight samples where Pseudo-
monas comprised of > 90% of sequence reads. We de-
tected Pseudomonas on selective agar for six of the eight
samples (two samples had no growth), which were iden-
tified as P. fluorescens (n = 3) and P. fragi (n = 3) by
MALDI-TOF MS.
Bacterial interactions
We examined the relationships between the 100 most
common OTUs using the network inference tool, SparCC
(Fig. 5). Of particular note for the correlation network, the
predominant Streptococcus OTU had positive relation-
ships with two of the Moraxella OTUs (r = 0.32, p < 0.001
and r = 0.34, p < 0.001) and the predominant Haemophi-
lus OTU (r = 0.36, p < 0.001); and a negative relationship
with Pseudomonas (r = 0.31, p < 0.001). There was no sig-
nificant interaction between Streptococcus and Dolosigra-
nulum (r = 0.03, p = 0.379).
Table 3 Median relative abundance (%) for the seven most
common genera by symptoms of an upper respiratory tract
infection (URTI)
No URTI
(n = 65)
URTI
(n = 67)
p value1
Pseudomonas2 0.04
(0.01–0.49)
0.04
(0.01–0.14)
0.348
Moraxella 7.51
(0.06–37.94)
30.55
(0.31–48.14)
0.044
Staphylococcus2 0.04
(0.01–0.17)
0.02
(0.01–0.17)
0.458
Dolosigranulum 32.75
(9.46–48.89)
15.08
(4.25–32.09)
0.044
Streptococcus2 0.55
(0.12–3.41)
1.57
(0.29–7.57)
0.040
Corynebacterium 13.54
(3.53–34.10)
2.61
(0.80–14.55)
0.039
Haemophilus2 0.04
(0.01–2.78)
0.81
(0.09–16.48)
0.002
Data are median (interquartile range)
1p value calculated following multivariable linear regression adjusting for
ethnicity, presence of URTI symptoms, exposure to household cigarette smoke,
breastfeeding status, year of swab collection, season of swab collection, antibiotic
use in the previous 2 weeks and sex. An interaction between vaccination status
and ethnicity was included in models for Pseudomonas
(p = 0.026), Dolosigranulum (p = 0.093), Streptococcus (p = 0.033) and Haemophilus
(p = 0.029), but not in models for Moraxella (p = 0.945), Corynebacterium (p = 0.387)
and Staphylococcus (p = 0.453)
2Log transformation of relative abundance was used in the linear regression models
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Fig. 3 nMDS of the dissimilarity in microbial composition by ethnicity and symptoms of an upper respiratory tract infection using abundance-
based (a) and binary-based (b) measures. Shown are iTaukei children, with (light blue) or without (dark blue) symptoms of an upper respiratory
tract infection, and FID children, with (light brown) or without (dark brown) symptoms of an upper respiratory tract infection. The centre points
represent the mean of each group and the lines represent distance from the mean for each sample. There was a significant difference between
the four groups (p = 0.001), p value calculated using PERMANOVA. Stress values for figures are 0.158 (a) and 0.216 (b)
Fig. 4 Relative abundance (%) heatmap including all 132 samples. Sample clustering is shown on the left-hand side. Taxa with a relative
abundance above 30% in at least one sample are shown at the bottom. Where multiple OTUs are from the same genus ‘.1’ has been used for
subsequent OTUs. ‘Others’ represents the remaining taxa in each sample. Clusters for samples have been coloured to show clustered groups:
Cluster 1 (shown in dark blue), Cluster 2 (shown in green) dominated by Moraxella, Cluster 3 (shown in yellow) dominated by Dolosigranulum,
Cluster 4 (shown in purple) dominated by Dolosigranulum and Corynebacterium, Cluster 5 (shown in orange) dominated by Haemophilus, and
Cluster 6 (shown in grey) dominated by Pseudomonas. The vaccination status (unvaccinated—blue; vaccinated—red), ethnicity (iTaukei—turquoise;
FID—gold) and whether the child had any symptoms of an upper respiratory tract infection (no URTI—light blue; URTI—brown) are shown in bars on
the right of the heatmap
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Discussion
There are limited data on the impact of pneumococcal
vaccination on respiratory microbiota, particularly from
children in low- and middle-income countries. We in-
vestigated the association between pneumococcal vac-
cination and nasopharyngeal microbiota in 12-month-
old Fijian children approximately 8.5 months after their
third dose of PCV7. Given that the two ethnic groups in
Fiji have marked differences in pneumococcal carriage
and disease prevalence, we examined the associations
with pneumococcal vaccination by ethnicity.
We found little evidence of a broader association be-
tween PCV7 and nasopharyngeal microbiota, beyond redu-
cing the relative abundance of Streptococcus in vaccinated
children compared with unvaccinated children. Our find-
ings were consistent with a study in Kenyan children aged
12–59months, where no differences were observed 4
months after vaccination [19]. Some effects of pneumococ-
cal vaccination have been observed in studies in Swiss chil-
dren with otitis media aged < 2 years, where vaccination
reduced commensals such as Streptococcaeae (excluding
pneumococci) and Corynebacteriaeae [20], and in Dutch
children aged 12months, where vaccinated children had
increased absolute abundance of Haemophilus and
Staphylococcus as well as Actinomyces, Rothia, Neisseria
and Veillonella [18]. There are some notable differences be-
tween these studies and ours, particularly with regard to
vaccine formulation and schedule and age at which micro-
biota was assessed. These differences include the third dose
of PCV in our study given to children at 14 weeks of age
compared to 11months of age in the Netherlands study
and the use of the 10-valent PCV in the Kenyan study ra-
ther than 7-valent PCV used in our study. Additionally, in
some cases, the laboratory methods (such as the sequen-
cing platform, the 16S rRNA region sequenced and the
DNA extraction method used) differed between studies
which may contribute to some differences in findings. Se-
quencing depth also varies between studies, and some
studies use a subsampling approach for analysis. We
conducted an exploratory analysis using subsampling
and found no observable differences (data not shown)
and therefore did not use subsampling in our ana-
lyses. We cannot exclude the possibility that other
methodological approaches, such as the use of other
DNA extraction methods, would yield slightly differ-
ent results. However, available data suggests that any
Fig. 5 Network correlation map based on the 100 most common OTUs considering samples from all 132 children. Shown are SparCC correlations
with p value < 0.05 and r > 0.3. The main OTUs from the top seven genera are shown by larger node size. Colours of nodes are grey except for
the seven most common genera. The edge (connecting line) colour represents a positive (green solid lines) or negative (red dashed lines)
correlation between two OTUs, with thicker lines representing stronger correlations. Only those correlations with genus-level classification are
shown and are labelled with the OTU genus
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PCV effects on nasopharyngeal microbiota may occur
soon after vaccination and may be transient.
Our previous studies in Fiji [25, 30] found significant
differences in bacterial carriage between iTaukei and FID
children but only examined a limited number of bacterial
species. Here, we found substantial differences in the en-
tire nasopharyngeal microbiota based on ethnicity. Ethni-
city influenced both microbial community structure, with
higher Shannon diversity in iTaukei children, and commu-
nity composition, with differences in the relative abun-
dance of five of the seven most common genera. Of the
participant characteristics collected, only weight and ex-
posure to household cigarette smoking differed between
the two ethnic groups, and in this study neither of these
had a significant association with microbial composition.
There are several genetic, environmental and social factors
which may contribute to the observed ethnic differences
in the microbiota [31]. Differences in genes associated
with immunity, such as beta-defensin and pattern recogni-
tion receptors have been associated with differences in the
nasopharyngeal microbiota and susceptibility to bacterial
infections [32, 33]. Polymorphisms, particularly in
immunity-related genes, have been linked to microbial
community composition, and patterns of polymorphisms
have shown to differ by geographic and ethnic origin [34,
35]. There is some evidence that Helcococcus, highlighted
as one of the most significant OTUs in the random forest
model for ethnicity, is associated with the presence of che-
mokine CXL8 [36], supporting a role for immune factors
in the observed ethnic differences.
The 2004 Fiji National Nutrition survey revealed several
dietary and lifestyle factors that differed between the two
ethnic groups including differences in consumption of
white meat (e.g. chicken) and preserved foods, as well as
levels of physical activity and cigarette use [37]. There is
some evidence that diet and composition of intestinal
microbiota may be determinants of respiratory microbiota
[38, 39]; however, information on diet (apart from breast-
feeding status) was not collected in our study.
Other household characteristics like social contact and/
or environmental factors may also be important in Fiji.
Recently, we undertook a social contact survey in Fiji,
finding that iTaukei children have a greater frequency of
physical contacts than FID children [40]. There is evi-
dence that social contact can influence microbiota [41]
but the relative importance of social contact compared
with other factors as a determinant of microbiota is un-
known. In Fiji, the two main ethnic groups have similar
household income [30] so it is unlikely that socio-
economic status, a known risk factor for pneumococcal
carriage [23], contributes to the observed differences in
nasopharyngeal bacteria between iTaukei and FID chil-
dren. Given the complexity and interconnected nature of
factors that can determine microbiota, it is likely multiple
factors are involved in the underlying differences in micro-
bial composition between ethnic groups in Fiji.
We next examined the associations with PCV7 after
stratifying by ethnicity. In iTaukei children, PCV7 vac-
cination was associated with reduced relative abundance
of both Streptococcus and Haemophilus, without associa-
tions with other common genera. We noted a positive re-
lationship between Streptococcus and Haemophilus, which
may underpin an indirect reduction in Haemophilus (i.e.
through a direct vaccine-induced reduction in Streptococ-
cus). However, there was no evidence that vaccination re-
duced the carriage prevalence or density of S. pneumoniae
or H. influenzae. While PCVs reduce carriage prevalence
of vaccine serotype S. pneumoniae, they generally have no
effect on overall S. pneumoniae carriage prevalence due to
serotype replacement by non-vaccine serotypes [42, 43],
and so the lack of an overall association in this study with
S. pneumoniae carriage prevalence is not unexpected. We
also saw no association between PCV7 and S. pneumoniae
carriage density despite the observed difference in relative
abundance of Streptococcus. However, as the density of S.
pneumoniae was an absolute measure rather than relative,
it is possible that differences in absolute abundance be-
tween unvaccinated and vaccinated children may explain
the discrepancy between the two sets of results. Consist-
ent with this, Bisbroek et al. [18] found that the absolute
abundance of total microbiota was much higher in vacci-
nated children compared with controls at 24months of
age.
In contrast to the effect in iTaukei children, PCV7 was
not associated with changes to the relative abundance of
Streptococcus, nor S. pneumoniae carriage prevalence or
density, in FID children. However, the relative abundance
of Dolosigranulum was significantly higher in vaccinated
FID children compared with unvaccinated FID children.
Dolosigranulum has been reported to have a negative rela-
tionship with S. pneumoniae [44], and as such, although
we noted no association between PCV7 and Streptococcus
and no direct interaction between Streptococcus and Dolo-
sigranulum, our findings may have been a result of earlier
interactions not captured in our sampling. For example, it
is plausible that pneumococcal vaccination may have had a
transient effect on Streptococcus directly after vaccine ad-
ministration, which may also have indirectly increased the
relative abundance of Dolosigranulum, in vaccinated FID
children. Microbiota profiles containing Dolosigranulum
are more stable than those containing Streptococcus [45],
and therefore it is possible that an effect may have been
maintained for Dolosigranulum but not Streptococcus.
The presence of URTI symptoms had a significant as-
sociation with nasopharyngeal microbiota. In children
with symptoms of an URTI, the relative abundances of
Streptococcus, Moraxella and Haemophilus was higher
and the relative abundance of Dolosigranulum and
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Corynebacterium was lower, compared with children
without URTI symptoms. Interestingly, when we looked
at community composition by ethnicity and URTI symp-
toms, we found that the microbiota of FID children with
URTI symptoms was similar to the microbiota of iTaukei
children without URTI symptoms, although the presence
of URTI symptoms shifted microbiota profiles in a simi-
lar direction for both ethnic groups. The association
with URTI symptoms and Moraxella and Haemophilus
is perhaps unsurprising given that there are known re-
spiratory pathogens within the genera which have been
linked to URTIs [46, 47]. Dolosigranulum and Coryne-
bacterium have been linked with a healthy nasopharyn-
geal microbiome, and the presence of Dolosigranulum
and Corynebacterium have been associated with a de-
creased risk of otitis media [44] as well as decreased epi-
sodes of respiratory tract infections [45, 48].
A limitation of this study is that viruses were not exam-
ined, and URTI symptoms may be related to viral infection.
De Steenhuijsen Piters et al. [49] found that respiratory
syncytial virus infection and hospitalisation was associated
with Streptococcus and Haemophilus in the nasopharyngeal
microbiota in children < 2 years of age. In adults, rhino-
virus decreased α-diversity and altered the relative abun-
dance of the genera Neisseria and Propionibacterium [50].
Contamination can be a significant problem in micro-
biome studies, particularly for low biomass samples [51].
We sequenced all the PCR products from the extraction
and PCR controls, as despite taking several measures to re-
duce contamination and repeating PCRs with no template
added, a PCR product was present in all our controls.
Contamination is difficult to eliminate in microbiome stud-
ies due to the presence of bacterial components in purified
water, DNA extraction kits and PCR reagents [51, 52]. The
OTU composition of the controls was substantially differ-
ent to the samples included in our analysis, giving confi-
dence in our findings. Furthermore, most of the abundant
genera in our study have been reported as predominant
genera in other studies [20, 53]. The exception is Pseudo-
monas, which is not commonly found in the nasopharynx,
but has been identified as a potential contaminant in sev-
eral studies [51, 54]. In our study, when Pseudomonas was
found, it was generally present at a high relative abundance
in participant samples and at a low relative abundance in
the ‘typical’ control profile (< 1% in 10 out 12 controls).
Samples containing Pseudomonas were distributed
across all seven rounds of DNA extractions. We con-
sider it unlikely that Pseudomonas is a contaminant in
our study, as viable Pseudomonas from two different
species were cultured from six out of eight samples for
which Pseudomonas accounted for > 90% of the relative
abundance. Nevertheless, when we removed these eight
samples from our analysis it did not affect the conclu-
sions of our study. Additionally, given that for other
Pseudomonas species such as P. aeruginosa acquisition
increases in warmer seasons and tropical climates [55,
56], it is plausible that nasopharyngeal carriage of
Pseudomonas may occur in Fiji.
A key strength of this study is that samples were ob-
tained from a randomised control trial in a setting where
PCV has not been introduced. Additionally, PCV7 was
not available on the private market when the samples were
collected, therefore herd effects are unlikely to impact un-
vaccinated participants in our study. This means that par-
ticipants would not be subject to any indirect effects of
PCV, and samples were collected during the same time
period and from children in a similar setting. Limitations
are that the samples were tested following approximately
10 years of storage at − 80 °C, that PCV7 has been re-
placed by higher valency vaccines (PCV10 and PCV13 are
currently in use globally) and that only a single time point
was tested. Long-term frozen storage may impact the
quality and quantity of DNA recovered from swab sam-
ples and has the potential to have an effect on the micro-
bial community structure [57]. However, any effects
related to storage are likely to be consistent between
groups and therefore would not affect overall conclusions.
One limitation of our study is the relatively small sample
size, which was partly due to ensuring that there were
even numbers of children from each ethnic group repre-
sented. Microbiota were not examined at baseline, and
groups were not randomised by baseline microbiota.
Given the small sample size, it is possible that baseline
microbiota may have varied between groups. As such, this
study was focussed on exploring associations between
PCV7 and nasopharyngeal microbiota rather than infer-
ring direct causality. Given the effect that a small sample
may have on some analyses, and potential issues of multi-
plicity, results should be interpreted with caution. Al-
though PCV7 affects fewer serotypes as PCVs with higher
valency, the mechanism of protection is the same; there-
fore, any trends observed are likely to be similar to those
observed for PCV10 or PCV13.
Conclusion
Overall, we found no significant wider association be-
tween PCV and nasopharyngeal microbiota. These results
suggest that the majority of replacement that occurs fol-
lowing the elimination of vaccine type pneumococci from
the nasopharynx is due to non-vaccine type pneumococci,
rather than other bacterial species. However, we found
distinct microbial profiles by ethnic group, as well as evi-
dence that the associations with pneumococcal vaccin-
ation varied between ethnic groups. Pneumococcal
vaccination reduced the relative abundance of Streptococ-
cus and Haemophilus in iTaukei children and increased
the relative abundance of Dolosigranulum in FID children.
Given the association of Streptococcus and Haemophilus
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with URTIs and the association of Dolosigranulum with a
healthy microbiome, we found that pneumococcal vaccin-
ation had positive associations with microbiota in both
ethnic groups.
Methods
Study design
The swabs used in this study were collected as part of
the FiPP, a phase II vaccine trial in Suva, Fiji [26–29].
Details of selection criteria, randomisation procedures
and results of the vaccine trial are reported elsewhere
[26–29] with key details of trial design found in Russell
et al. [27]. In brief, healthy infants were recruited from
three participating health centres and were stratified by
ethnicity and randomised into groups using a computer-
generated list. Participant information was collected by
nurses at enrolment (and at swab collection) from the
parent/guardian; this included demographic information
(e.g. date of birth, sex and ethnicity) and information on
known risk factors for pneumococcal colonisation (e.g. ex-
posure to household cigarette smoke, antibiotic use in the
previous two weeks and symptoms of an URTI). In this
study, we used a total of 144 nasopharyngeal swabs, 36
randomly selected from each of the four groups (iTaukei
and FID children; who were either unvaccinated or vacci-
nated with three doses of PCV7 at 6, 10 and 14 weeks of
age). Swabs were collected between 2005 and 2007 from
FiPP participants at 12months of age (prior to 23-valent
pneumococcal polysaccharide vaccine administration) and
stored and transported as previously described [26]. In
brief, buffered cotton swabs (aluminium shaft-buffered;
Sarstedt, Australia) were used to sample the nasopharynx
for 5 s, before being placed in a sterile cryovial (Simport,
Canada) containing 1ml of skim milk tryptone glucose
glycerol (STGG) medium. After chilled transport to the
Colonial War Memorial Hospital in Suva, Fiji, the swabs
were stored at − 70 °C. Swabs were transported on dry ice
to the Pneumococcal Research Laboratory at MCRI in
Melbourne, Australia, and stored at − 80 °C.
DNA extractions
DNA extractions were performed in batches of 23 sam-
ples (total of seven batches) plus a negative control
(empty sterile 1.5-ml microfuge tube) using the QIamp
DNA Mini Kit (Qiagen). In a biohazard class II cabinet,
200 μl of swab STGG was aliquoted into a sterile 1.5-ml
microfuge tube for each sample. These aliquots were then
spun in a centrifuge for 5min at 6000×g to create a pellet.
Pellets were placed at − 80 °C for 15min to promote cell
lysis. Following the freeze/thaw step, 200 μl of enzymatic
lysis buffer (containing 36.25mM phosphate buffer, 1 mg/
ml lysozyme, 0.075mg/ml mutanolysin and 2mg/ml pro-
teinase K) was added, followed by incubation at 56 °C for
45min. An additional 20 μl of proteinase K (20mg/ml,
Qiagen) was added before further incubation at 56 °C for
10min. 4 μl of RNase A (at 100 μg/ml, Qiagen) was added
and mixed gently at room temperature for 2min before
adding 200 μl of buffer AL. Samples were then incubated
at 70 °C for a further 10min to complete cell lysis. Extrac-
tions were then performed according to the manufac-
turer’s instructions with DNA eluted in 100 μl of Buffer
AE and DNA stored at − 30 °C.
16S rRNA gene PCR
The V4 region of the 16S rRNA gene was amplified by
PCR using a primer pair which included the Illumina-
specific adapter sequences (Table 4). Each PCR was per-
formed using 1 μM of each primer (HPLC purified in li-
quid at 100 μM concentration, Sigma-Aldrich, Australia),
1X Phusion Green Hot Start II High-Fidelity PCR Master
Mix (Thermo Fisher Scientific) and 10 μl of extracted
gDNA in a 50-μl reaction. Each PCR run included a no
template control which was sequenced along with extrac-
tion controls. Following an initial denaturation step at
98 °C for 30 s, there were 35 cycles of denaturation at
98 °C for 5 s, annealing at 65 °C for 20 s and elongation at
72 °C for 15 s, followed by a final elongation step at 72 °C
for 5 min. PCR products were then stored at − 20 °C. PCR
products from the V4 PCR were purified using AMPure
XP beads and following the Illumina ‘16S Metagenomic
Sequencing Library Preparation’ protocol (Part #
15044223 Rev. B). PCR product sizes and concentrations
were measured by running samples on a TapeStation Sys-
tem (Agilent Technologies) using the D1000 ScreenTape
System (Agilent Technologies). MiSeq sequencing was
performed by the Translational Genomics Unit at MCRI,
Melbourne, Australia. Initially, a sequencing run of 22
samples (plus the extraction control and the no template
PCR control) was performed, with the remaining samples
and controls then sequenced in two batches. As the se-
quencing depth varied between the initial sequencing run
and the two batches performed later, four of the initial 22
samples were also included in the later sequencing batches
to check results that did not differ by sequencing depth.
Table 4 16S rRNA PCR primers for V4 region plus illumina adapter
Region Product size (bp)* Primer Sequence (5′ > 3′)
V4 ~ 250 515F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG GTGCCAGCMGCCGCGGTAA
806R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG GGACTACHVGGGTWTCTAAT
*Exact product size varies between bacterial species. Illumina adapter sequence is underlined
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The V4 purified DNA was prepared for sequencing
using the Illumina ‘16S Metagenomic Sequencing Library
Preparation’ protocol (Document # 15044223 Rev. B). The
libraries were sequenced using Illumina MiSeq V3 reagent
kits (2 × 300 bp) on the MiSeq platform (Illumina).
Sequence processing
Raw sequences were processed and classified using
MOTHUR (version 1.35.1) [58] following the MiSeq SOP
(http://www.mothur.org/wiki/MiSeq_SOP; accessed 27
July, 2015) and Silva nr (v119) classification database [59].
Sequences with read lengths falling outside a 225–325
base pairs (bp) range, any ambiguous bases and > 8 bp ho-
mopolymers were removed. Sequences were aligned
across the region spanning the forward and reverse
primers, and any overhang was trimmed. Chimeric se-
quences were identified and removed using UCHIME [60]
and sequences were clustered into OTUs at 97% similarity
to the genus level. OTUs for which > 33% of sequence
reads were from controls were removed from count data
to reduce background signal. Samples which had less than
50,000 sequence reads were removed from further ana-
lysis, as were any samples that shared greater than 20%
identity (based on relative abundance) to the controls
(both extraction and PCR) in downstream analysis as
these were considered to have amplified little, if any, bac-
terial DNA from the swab.
Species-specific qPCR
Species-specific qPCR assays were used to detect, and deter-
mine the carriage densities, of the respiratory pathogens S.
pneumoniae, Staphylococcus aureus, Moraxella catarrhalis
and Haemophilus influenzae [25]. Two duplex assays were
performed using primers (Sigma-Aldrich), probes (Eurogen-
tec) and concentrations as described previously [30]. Sam-
ples were run in duplicate wells using 2 μl of extracted
DNA and Brilliant III Ultra-Fast qPCR Master Mix (Agilent
Technologies). Standard curves for each species were pre-
pared using a dilution series of DNA extracted from S.
pneumoniae ATCC 6305, H. influenzae F412,M. catarrhalis
ATCC 8176 and S. aureus ATCC 29213. Duplex qPCRs
were performed on a Stratagene Mx3005 instrument with
40 cycles of 95 °C for 20 s and 60 °C for 20 s after an initial
activation of 95 °C for 3min. Results were analysed using
MxPro™ software (Stratagene) and genomic equivalents per
millilitre determined for each sample.
Pseudomonas culture
Eight samples (FM052, FM108, FM029, FM001, FM004,
FM129, FM057, FM020) which contained Pseudomonas
at a relative abundance > 90% were cultured on cepha-
loridine fucidin cetrimide (CFC) agar (Oxoid, Thermo
Fisher) at 28 °C for 48 h. Isolated colonies were then
confirmed as Gram-negative bacilli that were oxidase
positive and identified by MALDI-TOF MS using the
Vitek® MS system (bioMérieux).
Analyses
Analyses were conducted and graphs were generated using
GraphPad Prism version 7.02 unless otherwise stated. P <
0.05 was considered statistically significant. Relative abun-
dance was defined as the percentage of total sequence reads
from an individual sample that were from the specific OTU,
genus or family being considered. Relative abundance (%)
data was used as input for analyses unless otherwise stated.
For comparing carriage prevalence from the species-
specific qPCR data, Fisher’s exact test was used. For com-
paring carriage densities from the species-specific qPCR,
data were first checked for normality using the D’Agostino
& Pearson normality test. For normally distributed data,
an unpaired t test was used. Where data were not nor-
mally distributed, the Mann-Whitney test was used.
Alpha-diversity (i.e. within sample diversity) was deter-
mined through OTU richness (number of OTUs) and
Shannon diversity index. Alpha-diversity measures were
calculated using R Studio (version 3.2.4) and the ‘diversity’
function of the vegan package (version 2.3-5) [61]. Rich-
ness calculations were rarefied to account for differences
in sequencing depth, as greater sequencing depth in-
creases the number of OTUs or richness. Rarefaction was
done by subsampling 50,000 sequence reads (based on the
lowest number of reads—53,616 reads) using the ‘rarefy’
function in vegan package. Beta-diversity (i.e. between
sample diversity) was calculated using a Jaccard distance
matrix (‘vegdist’ function, R vegan package) using both
abundance-based (default setting) and binary-based
(binary = TRUE) measures with nMDS plots (‘metaMDS’
function, vegan package) as the ordination method. Per-
mutational multivariate analysis of variance (PERMA-
NOVA, ‘adonis’ function, R vegan package) was used to
calculate significant differences in microbial composition
between groups.
A heatmap of microbial composition in all samples
was generated in R using the following packages: vegan,
RColorBrewer (version 1.1-2), gplots (version 3.0.1) and
dendextend (version 1.7.0). Samples and OTUs were
clustered using the ‘hclust’ function and the average link-
age method based on a Jaccard distance matrix. For gen-
erating the heatmap, OTUs were filtered to only those
with a relative abundance above 30% in at least one sam-
ple. Clusters were characterised using the ‘cascadeKM’
function (vegan package) with the default ‘calinski’ criter-
ion (Calinski-Harabasz [62]) and coloured using the
‘color_branches’ function (dendextend package).
To examine co-presence or mutual-exclusion of the
most abundant OTUs, a correlation network was gener-
ated using count data and the default SPARCC [63] param-
eters in MOTHUR after filtering to the top 100 most
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abundant OTUs. The SPARCC data was then formatted
and analysed in R. Only correlations with a significance of
p < 0.05, a correlation r > 0.3 and OTUs with a classifica-
tion to the genus level were included in the network.
Networks were visualised and edited using Cytoscape soft-
ware version 3.3.0 [64].
Random forest models were used for each risk factor to
rank OTUs on their ability to discriminate between groups
(see Additional file 4: Table S4). The random forest analysis
was done in RStudio using R packages ‘randomForest’ ver-
sion 4.6-14, ‘pylr’ version 1.8.4 and ‘rfUtilities’ version 2.1-3.
Using relative abundance data, rare OTUs that were zero
in greater than 95% of samples were removed, data were
then normalised back to 100%. Each risk factor was ana-
lysed in separate models using the ‘randomForest’ and
‘rf.significance’ functions. Each model used the parameters
‘ntree = 501’, ‘importance = TRUE’ and ‘proximities =
TRUE’, and significance was calculated using 500 permuta-
tions. The mean decrease in accuracy or variable import-
ance was examined in each model for the top 10 OTUs.
Multivariable linear regression (Additional file 5 and
Additional file 6) was done in RStudio using the ‘lm’ func-
tion (base ‘stats’ package in R, version 3.2.4) for looking at
specific associations with vaccination and ethnicity on
pooled genus data or α-diversity measures. For each model,
an interaction term between vaccination and ethnicity was
considered and Akaike information criterion was used to
determine whether inclusion of the interaction term was
appropriate. As well as vaccination status and ethnicity,
final models included the following risk factors: symptoms
of an URTI (such as runny nose or cough), breastfeeding
status, household exposure to cigarette smoke, the year the
swab was collected, season of swab collection, antibiotic
use in the previous two weeks and sex of the child. Each
model also included the sequence count for each sample
to account for potential differences in sequencing depth
between samples. Checks of the normality of residuals
were performed using the ‘plot’ function in R, in cases
where residuals were not normal, data were log
transformed.
Additional files
Additional file 1: Participant characteristics. Participant characteristics
stratified by ethnicity (Table S1.) and by vaccination status (Table S2.).
As well as participant characteristics for those included in this study vs.
those not included (Table S3.). (DOCX 22 kb)
Additional file 2: Richness and Shannon diversity. Plots of richness and
Shannon diversity index (Figure S1.) by vaccination status (a and b), by
ethnicity (c and d) and by vaccination status within each ethnic group
(e and f). (DOCX 674 kb)
Additional file 3: Species-specific qPCR data. Species-specific qPCR
results (carriage prevalence and density) for S. pneumoniae, H. influenzae,
M. catarrhalis and S. aureus by vaccination status (Figure S2.), ethnicity
(Figure S3.) and vaccination status after stratifying by ethnicity
(Figure S4.). (DOCX 954 kb)
Additional file 4: Association between microbial composition and
participant characteristics by PERMANOVA and random forest models.
Table (Table S4.) of the PERMANOVA and random forest results for each
of the participant characteristics. (DOCX 19 kb)
Additional file 5: URTI symptoms and ethnicity. Table (Table S5.) of the
median relative abundance (%) for the seven most common genera by
symptoms of an upper respiratory tract infection (URTI) after stratifying by
ethnicity. (DOCX 15 kb)
Additional file 6: Linear regression data. Unadjusted (Table S6.) and
adjusted (Table S7.) linear regression results, as well as this data
following log transformation (Tables S8 and S9.) for models that were
log transformed. (DOCX 28 kb)
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